2026 NPPES data Nephrology Physician NPI 1528145620 MD
Verify on CMS →

MARIA ERAZO, MD

Nephrology Physician in ALLENTOWN, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
8K
Medicare Part D claims · 126 beneficiaries · Nephrology Physician avg: 1K
Generic prescribing
68%
generic claims · 32% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$664.06
26 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARIA ERAZO, MD filed 7,974 Medicare Part D claims in 2023 as a Nephrology Physician in ALLENTOWN, Pennsylvania, prescribing 68% generic.

8K
Part D claims, 2023
68%
generic prescribing
$664.06
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARIA ERAZO, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

7,974 Top 3% higher than 97% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

MARIA ERAZO, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARIA ERAZO, MD?

Quality data not reported

NPI registry status

Active

Issued 11/01/2006

NPI 1528145620

Primary specialty

Nephrology Physician

Mid-sized

10,534 US NPIs in this specialty

Medicare Part D claims

7,974 448% vs specialty avg

2023 prescription claims

Specialty avg: 1,454

Specialty distribution in Pennsylvania

How Nephrology Physician compares to other specialties among Pennsylvania providers

Pennsylvania providers

Nephrology Physician share within Pennsylvania

1. Nephrology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Nephrology Physician share within Pennsylvania

Specialty board-certification context

Estimated specialty board-certified rate — Nephrology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Nephrology Physician ABMS/AOA estimate

Est. board-certified rate (Nephrology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Nephrology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARIA ERAZO, MD appears in the CMS NPPES registry as a Nephrology Physician provider holding MD credentials at 451 CHEW ST, ALLENTOWN, PA, 18102, with a listed phone of (610) 973-3391. NPI 1528145620 was issued on 11/01/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ERAZO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 7,974 prescription claims written by this provider, covering 126 Medicare beneficiaries and totaling roughly $2.8 million in drug spend, split 32% brand-name and 68% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Nephrology Physician is a mid-sized specialty nationwide, with 10,534 enrolled providers across 55 states and an average of 1,454 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

451 CHEW ST
ALLENTOWN, PA 18102

Provider Details

NPI 1528145620
Specialty Nephrology Physician
Credentials MD
Gender Female
NPI Issued 11/01/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARIA ERAZO, MD. Source: openpaymentsdata.cms.gov.

Total received

$664

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to MARIA ERAZO, MD. To verify MARIA ERAZO, MD's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

MARIA ERAZO, MD — brand share 32.0%
Specialty average (est.)

32% brand-name claims vs 68% generic, on 7,974 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

7,974
Total Claims
$2.8M
Total Drug Cost
126
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
13,021
Total Day Supply
383,194
Brand vs Generic
32% brand / 68% generic
Brand Drug Cost
$2.4M
Generic Drug Cost
$229K

Patient Demographics

Average Patient Age
69.5 years
Avg HCC Risk Score
2.05
Gender Split
56% female / 44% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARIA ERAZO, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Vascepa
Icosapent Ethyl
302
Bromocriptine Mesylate
259
Atorvastatin Calcium
246
Rosuvastatin Calcium
246
Famotidine
230
Diclofenac Sodium
213
Kerendia
Finerenone
212
Ezetimibe
203
Metformin Hcl
202
Jardiance
Empagliflozin
182

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Nephrology Physician Overview

How MARIA ERAZO, MD fits within the Nephrology Physician landscape nationally.

10,534
Nephrology Physician Providers in US
55
States with Nephrology Physician
1,454
Avg Claims per Provider

MARIA ERAZO, MD's 7,974 claims are above the specialty average of 1,454.

Nearby Nephrology Physician Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as ERAZO.

Compare Nephrology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARIA ERAZO, MD's specialty?
MARIA ERAZO, MD specializes in Nephrology Physician and practices in ALLENTOWN, Pennsylvania. Credentials: MD.
How much does MARIA ERAZO, MD prescribe under Medicare Part D?
In 2023, MARIA ERAZO, MD wrote 7,974 Medicare Part D claims totaling $2.8M in drug costs for 126 beneficiaries.
Where is MARIA ERAZO, MD located?
MARIA ERAZO, MD is located at 451 CHEW ST, ALLENTOWN, PA, 18102. Phone: (610) 973-3391.
What is MARIA ERAZO, MD's NPI number?
MARIA ERAZO, MD's National Provider Identifier (NPI) is 1528145620, issued on 11/01/2006.
Does MARIA ERAZO, MD prescribe more brand-name or generic drugs?
MARIA ERAZO, MD's prescribing is 32% brand-name and 68% generic drugs by claim count, with $2.4M in brand drug costs.
How many Nephrology Physician providers are there in the US?
There are 10,534 Nephrology Physician providers across 55 states in the US. The average Nephrology Physician provider writes 1,454 Medicare Part D claims per year.
What drugs does MARIA ERAZO, MD prescribe most often?
Based on 2023 Medicare Part D data, MARIA ERAZO, MD's most frequently prescribed drugs include Vascepa, Bromocriptine Mesylate, Atorvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARIA ERAZO, MD accept Medicare?
MARIA ERAZO, MD appears in CMS Medicare data with 7,974 Part D claims and 126 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARIA ERAZO, MD's credentials?
MARIA ERAZO, MD's NPI is 1528145620 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology